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Volumetric muscle loss (VML) can result from trauma, infection, congenital anomalies,
or surgery, and produce permanent functional and cosmetic deficits. There are no
effective treatment options for VML injuries, and recent advances toward development
of muscle constructs lack the ability to achieve innervation necessary for long-term
function. We sought to develop a proof-of-concept biomaterial construct that could
achieve acetylcholine receptor (AChR) clustering on muscle-derived cells (MDCs) in vitro.
The approach consisted of the presentation of neural (Z+) agrin from the surface of
microspheres embedded with a fibrin hydrogel to muscle cells (C2C12 cell line or
primary rat MDCs). AChR clustering was spatially restricted to areas of cell (C2C12)-
microsphere contact when the microspheres were delivered in suspension or when they
were incorporated into a thin (2D) fibrin hydrogel. AChR clusters were observed from
16 to 72 h after treatment when Z+ agrin was adsorbed to the microspheres, and
for greater than 120 h when agrin was covalently coupled to the microspheres. Little
to no AChR clustering was observed when agrin-coated microspheres were delivered
from specially designed 3D fibrin constructs. However, cyclic stretch in combination
with agrin-presenting microspheres led to dramatic enhancement of AChR clustering in
cells cultured on these 3D fibrin constructs, suggesting a synergistic effect between
mechanical strain and agrin stimulation of AChR clustering in vitro. These studies
highlight a strategy for maintaining a physiological phenotype characterized by motor
endplates of muscle cells used in tissue engineering strategies for muscle regeneration.
As such, these observations may provide an important first step toward improving
function of tissue-engineered constructs for treatment of VML injuries.
Keywords: bioreactor, drug delivery, fibrin, microspheres, tissue engineering, regenerative medicine
Abbreviations: α-BTX, alpha bungarotoxin; AChR, acetylcholine receptor; B&C, brightness and contrast; BSA, bovine
serum albumin; CA, cellulose acetate; CaCl2, calcium chloride; LD, latissimus dorsi; MDC, muscle-derived cell; MEP, motor
endplate; MES, 2-(N-morpholino)ethane sulfonic acid; NHS, N-hydroxysulfosuccinimide sodium salt; NMJ, neuromuscular
junction; PBS, phosphate-buffered saline; rMDC, rat muscle-derived cell; siO2, silicon dioxide; TA, tibialis anterior; TBST,
Tris-buffered saline with Tween; TEMR, tissue-engineered muscle repair; VML, volumetric muscle loss.
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INTRODUCTION
The ability to voluntarily control skeletal muscle is critically
important to key daily functions such as locomotion, breathing,
and postural support. Skeletal muscle possesses an inherent
capacity for self-repair following injury. The repair process
consists of a series of phases that start with inflammation followed
by satellite cell mobilization and, ultimately, to maturation of
myofibers and remodeling of muscle architecture (Charge and
Rudnicki, 2004; Jarvinen et al., 2005; Ambrosio et al., 2009;
Ciciliot and Schiaffino, 2010). However, this repair process is
insufficient in more extensive injuries, resulting in extensive scar
tissue formation (Jarvinen et al., 2005). These larger injuries in
which the muscle damage results in permanent functional and
cosmetic defects are referred to as VML injuries (Grogan and
Hsu, 2011). Although VML can result from a variety of causes
including congenital abnormalities, acquired disease and tumor
resection, the most devastating injuries generally result from
trauma. Traumatic VML injuries in the civilian population result
from causes such as automobile accidents (and gun shot wounds)
(Mazurek and Ficke, 2006) and in military personnel from high
impact forces (Mazurek and Ficke, 2006; Owens et al., 2008; Lew
et al., 2010).
Surgical treatment of VML injuries by autologous tissue
transfer is limited by limited donor tissue, donor site morbidity
and poor engraftment (Khouri et al., 1998; Lin et al., 1999;
Lawson and Levin, 2007). Alternative strategies for VML repair
include cell transplantation (Ni et al., 2014; Oshima et al.,
2014) platelet-rich plasma (Hamid et al., 2014), growth factors
(Dumont and Frenette, 2013), hyperbaric oxygen inhalation
(Horie et al., 2014), gene therapy (Jang and Shea, 2006), and
traditional pharmacological approaches (Vignaud et al., 2005;
Kobayashi et al., 2013). However, none of these strategies restore
satisfactory function.
Because existing clinical treatments are lacking, numerous
tissue engineering approaches are being investigated as
alternatives to achieve skeletal muscle repair and regeneration.
The tissue engineering triad consists of some combination
of biomaterial scaffolds, cells, and signals (e.g., mechanical
or chemical signaling) (Lanza et al., 2014), and each of these
have been investigated for capability to achieve skeletal muscle
regeneration. Synthetic or naturally derived biomaterial scaffolds
have been used alone, without addition of cells or signals
(Badylak et al., 2001; Crow et al., 2007; Kin et al., 2007; Dufrane
et al., 2008; Merritt et al., 2010b; Valentin et al., 2010; McKeon-
Fischer et al., 2011; Perniconi et al., 2011; Sicari et al., 2012;
Turner et al., 2012; Sun et al., 2013). Alternatively, biomaterials
have been used in conjunction with cells in an effort to further
improve in vivo outcomes (Fujita et al., 2010; Borselli et al., 2011;
Hinds et al., 2011; Machingal et al., 2011; Page et al., 2011; Rossi
et al., 2011; Corona et al., 2012, 2013, 2014; Monge et al., 2012;
Du et al., 2013; Martin et al., 2013; Williams et al., 2013; Juhas
and Bursac, 2014; Juhas et al., 2014; VanDusen et al., 2014; Wang
et al., 2014) (for a recent review of these studies, see, Christ et al.,
2015). Incorporation of signals has included chemical cues such
as pharmacological molecules/growth factors (Falco et al., 2011;
Sato et al., 2011; Bian and Bursac, 2012; Koning et al., 2012;
Wang et al., 2012, 2014; Yun et al., 2012; Ko et al., 2013) or
mechanical cues such as mechanical stretch (Vandenburgh and
Karlisch, 1989; Vandenburgh et al., 1989, 1991; Moon du et al.,
2008; Machingal et al., 2011; Corona et al., 2012). In each case,
the goal is to identify a strategy in which a micro-environment
more favorable to skeletal muscle regeneration can be achieved.
Despite progress toward improved outcomes (e.g., contractile
force), we are not aware of any reports of full functional recovery
in biologically relevant animal models. One possible reason
for the lack of long-term success is the micro-environmental
role played by axons that innervate the muscle and form
NMJs (Sanes and Lichtman, 2001; Madhavan and Peng, 2005;
Witzemann, 2006; Wu et al., 2010). In native, healthy muscle
tissue innervation is indicated by the formation of a mature post-
synaptic apparatus known as the motor end plate (MEP) (Sanes
and Lichtman, 2001; Madhavan and Peng, 2005; Witzemann,
2006; Wu et al., 2010). In non-VML injuries to skeletal muscle,
re-innervation is achieved when endplates remain present (Frank
et al., 1975; Carlson and Faulkner, 1988; Dedkov et al., 2002).
Further, it is well-known that muscle cells atrophy if chronically
denervated (Jarvinen et al., 2005). Thus, the lack of MEP
in muscle cells used for current tissue engineering strategies
for VML injuries, coupled to the slow rate of axon growth
(∼1 mm/day) (Gutmann et al., 1942; Gordon et al., 2008; Kang
and Lichtman, 2013) is likely a significant contributing factor to
the lack of functional recovery in VML injury models.
Strategies capable of maintaining the presence of MEPs
on tissue engineered skeletal muscle during the neural re-
innervation process could have important implications on the
ability to ultimately achieve functional restoration in vivo. In
innervated skeletal muscle, the MEP is a complex structure in the
muscle membrane that contains sodium–potassium ion channels,
binding sites for acetylcholinesterase (the enzyme responsible for
degradation of acetylcholine), and AChR clusters. Each of these
components is critical to the function of the MEP and, ultimately,
the function of a neuro-muscular junction. Thus, an important
step toward the formation of MEPs is the formation of AChR
clusters (Daggett et al., 1996; Burgess et al., 1999; Sanes and
Lichtman, 2001; Bezakova and Ruegg, 2003; Madhavan and Peng,
2005; Witzemann, 2006; Wu et al., 2010).
However, we are unaware of any biomaterials approaches
compatible with tissue engineering strategies that have
investigated such an approach. In this report, we describe
our initial efforts to develop biomaterial constructs capable of
inducing AChR clustering as a step toward generation of MEPs
that ultimately may promote better in vivo function of tissue
engineered skeletal muscle for VML. The approach described in
this report consisted of adsorbing or covalently coupling neural
agrin (a known AChR clustering molecule) onto microspheres
capable of achieving a spatially regulated delivery of agrin (see
next paragraph) to cells in order to promote AChR clustering.
Further, these microspheres were then incorporated into fibrin
hydrogels, as shown schematically in Figure 1, in order to allow
presentation of the agrin from the fibrin hydrogels in a localized
manner that can achieve localized AChR clustering. Further, the
subsequent immobilization of agrin-bound microparticles in the
hydrogels is expected to greatly reduce diffusion of the agrin
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FIGURE 1 | Schematic of 3D tissue engineered muscle construct fabrication, seeding, and preconditioning. (A) Pharmacologic delivery vehicles were
created by covalent immobilization of agrin on a microsphere surface. These agrin microspheres were then suspended in a solution of fibrinogen, which was (B)
polymerized to fibrin around a sacrificial template of polymer fibers, as previously described (Scott et al., 2011). Selective dissolution of the template resulted in a
patterned hydrogel material of known mechanical properties (Scott et al., 2011) that presented agrin via embedded microspheres. (C) Scaffolds were then seeded
by manually pipetting a suspension of MDCs over the scaffold surface. Resident cells then received a combination of pharmacologic cues from scaffold agrin and/or
(D) mechanical cues from cyclic stretch in a bioreactor. (E) A tissue engineered construct fabricated using this approach after cell seeding and bioreactor
preconditioning.
away from the construct, potentially enhancing its long-term
activity.
Neural agrin is a heparan sulfate proteoglycan noted for its
ability to induce clustering of plasma membrane-bound AChRs
in skeletal muscle cells. This clustering behavior is unique to agrin
isoforms featuring a splice insert at the Z-site that is specific to
nerve-derived (Z+) agrin (Burgess et al., 1999). Studies to date
exploring neural agrin functionalization for skeletal muscle tissue
engineering applications have shown enhanced AChR cluster
formation, dystrophin gene expression, and force production in
tissue engineered skeletal muscle constructs when cultured in
media containing agrin (Bian and Bursac, 2012; Ko et al., 2013).
However, these studies have exclusively employed soluble agrin
conditioning in vitro, which would not be capable of maintaining
the localized agrin signal required within the TEMR construct
once implanted in vivo. This distinction is important, as neural
agrin in vivo is immobilized in the synaptic basal lamina, and
thus, restricted to areas of nerve-muscle contact (Wu et al., 2010).
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Fibrin hydrogels were used as the biomaterial for these
studies because their hydrogel nature is highly compatible with
incorporation of agrin-coated microspheres in a way not as
readily achieved with other biomaterials such as bladder acellular
matrix. These materials are also compatible with strategies to
achieve alignment of myofibers and, importantly they provide
sufficient mechanical integrity for in vitro bioreactor pre-
conditioning when fabricated by a sacrificial templating method
(Scott et al., 2011). This material requirement is important, as
previous studies by our group have shown that within 2 months
of implantation, TEMR constructs subjected to biomechanical
preconditioning in vitro produce significant improvements in
the rate and/or magnitude of functional recovery compared to
implantation of the material alone or the TEMR constructs
without bioreactor preconditioning (Machingal et al., 2011;
Corona et al., 2012). These findings clearly indicated that in vitro
preconditioning of TEMR constructs has an important impact
on subsequent functional recovery of VML injuries following
implantation in vivo.
The overarching hypothesis underlying the studies in this
manuscript is that one reason for lack of functional restoration in
tissue-engineered approaches to VML is the lack of innervation
from the native peripheral system, which itself is related to
lack of AChR clustering. The goals of these studies, then, were
three-fold. First, we sought to describe the development of a
novel approach to incorporate microsphere-immobilized neural
agrin into biomaterial constructs. We then investigated the
enhancement of AChR clusters on either a myoblast cell line
(C2C12 cells) or on primary rat MDCs in order to assess the
efficacy of the strategy for TEMR applications. Lastly, we sought
to investigate whether the microsphere agrin-delivery strategy
would be compatible and/or synergistic with our previous efforts
to apply cyclic stretch to TEMR constructs. While these studies
are largely proof-of-concept in nature, the results demonstrate an
important step in developing biomimetic materials that achieve
and maintain a key phenotypic characteristic of cells to be used
for TEMR approaches to VML. Incorporation of a strategy such
as the one described here may play a key role in the further
development of tissue-engineered scaffolds for VML.
MATERIALS AND METHODS
Preparation of Microspheres with
Adsorbed or Covalently Coupled Agrin
For control experiments in which agrin was delivered in solution-
phase (not adsorbed to microspheres), culture medium was
prepared by diluting recombinant rat agrin (R&D Systems,
Minneapolis, MN, USA) stock at 100 µg/mL (∼1.11 µM) in
sterile PBS by using an appropriate culture medium (specific to
each experiment described below). The final agrin concentration
was 50 ng/mL (∼0.56 nM).
Agrin-adsorbed (non-covalently bound) microspheres were
prepared from either 10 µm diameter Polybead R© microspheres
for epifluorescence experiments or 10 µm diameter Fluoresbrite R©
yellow green microspheres for confocal experiments described
below (both Polysciences, Inc., Warrington, PA, USA). Different
beads were used for these experiments to optimize fluorescence
on each system based on filters/lasers available. Microspheres
were first centrifuged from stock into a pellet and then sterilized
by resuspension to a concentration of ∼34 million particles/mL
in 95% v/v ethanol in water and agitation on a lab roller for
at least 15 min at ∼22◦C. Subsequent steps were carried out
in a biological safety cabinet to maintain sterility. Microspheres
were centrifuged and washed in sterile water twice to remove
residual ethanol before being resuspended from a pellet to a
concentration of∼84 million particles/mL (calculated by dilution
over sequential steps of the listed stock concentration provided
by the manufacturer) in 100 µg/mL agrin stock and agitated on a
lab roller for at least 1 h at ∼22◦C to allow for agrin adsorption.
Finally, microspheres were centrifuged and washed in sterile
water three times to remove non-adsorbed agrin and then
resuspended to a functional microsphere stock concentration of
∼48 million particles/mL in sterile water, in which form they were
stored statically at 4◦C for up to 2 months before use.
Covalently bound agrin microspheres were prepared by
using the zero-length crosslinker N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC, Sigma-Aldrich, St.
Louis, MO, USA) to link amine groups on agrin molecules
to either 10 µm diameter Fluoresbrite R© yellow green
carboxylate microspheres (Polysciences) or 10 µm diameter
SiO2 microspheres (Corpuscular, Cold Spring, NY, USA)
depending on the experiment described below. Fluoresbrite R©
polystyrene microspheres were selected because they provided
better fluorescence for confocal microscopy. SiO2 microsphere
were used in some experiments because the other microspheres
were not compatible with the acetone used for fabrication of
3-D fibrin hydrogels formed by a sacrificial templating approach
(see below). Though SiO2 microspheres were translucent under
confocal microscopy, they were visible within the scaffold as
they contrasted with the surrounding autofluorescent fibrin.
Each type of microsphere was first centrifuged from stock
into a pellet and then washed twice in MES buffer (pH 5.7),
consisting of 0.1 M MES (Acros Organics, Geel, Belgium) and
0.5 M NaCl (Sigma). Microspheres were then centrifuged and
resuspended to ∼42 million particles/mL in an intermediate
crosslinking solution consisting of MES buffer with 10 mg/mL
(52 mM) EDC and 10 mg/mL (46 mM) sulfo-NHS (Sigma). This
intermediate suspension was agitated on a lab roller for 15 min
at ∼22◦C before being quickly centrifuged and washed twice in
PBS (Thermo Fisher Scientific), pH 7.4. These functionalized
microspheres were centrifuged to a pellet and crosslinking to
agrin was accomplished by resuspending to a concentration of
∼42 million particles/mL in a 50 µg/mL (∼560 nM) solution of
agrin in PBS and agitating on a lab roller for at least 6 h at∼22◦C.
Agrin-bound microspheres were subsequently centrifuged,
resuspended at a concentration of ∼34 million particles/mL in
a solution of 95% v/v ethanol in water, and agitated on a lab
roller for at least 30 min at ∼22◦C to both remove any agrin
simply adsorbed to the microsphere surface as well as to sterilize
the microspheres. Finally, microspheres were centrifuged and
washed twice with sterile water in a biological safety cabinet to
remove residual ethanol and then resuspended to a functional
microspheres stock concentration of∼48 million particles/mL in
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sterile water, in which form they were stored statically at 4◦C for
up to 3 months before use.
Several negative controls were used as described in
experiments below. As a negative control to agrin-adsorbed
microspheres, 10 µm diameter Polybead R© microspheres were
sterilized in ethanol and washed in sterile water as above, but
were not subjected to further manipulation. As a negative
control to covalently bound agrin microspheres in 2D model
systems, Polybead R© carboxylate microspheres or Fluoresbrite R©
yellow green carboxylate microspheres were sterilized in ethanol
and washed in sterile water as above, but were not subjected
to further manipulation. Covalently bound BSA (Sigma) was
used as another negative control for the covalently bound agrin
microspheres. The BSA was covalently attached to Polybead R©
carboxylate microspheres as described above for agrin except
that BSA at 36.7 µg/mL (∼560 nM) in 50% v/v PBS/deionized
water was used.
Culture Medium Formulation
Four different culture media formulations were used in
experiments described below, with all components from Thermo
Fisher Scientific (Waltham, MA, USA) unless otherwise specified.
C2C12 growth medium consisted of high-glucose Dulbecco’s
modified Eagle’s medium (DMEM), 10% v/v heat-inactivated
fetal bovine serum (FBS), and 1% penicillin/streptomycin.
Differentiation medium, myogenic medium, and rMDC
growth medium (previously referred to as seeding medium)
compositions were prepared as previously described (Machingal
et al., 2011; Corona et al., 2012). Experimental cell cultures
in vitro described below were supplemented with agrin either
dissolved within culture medium or bound to the surface of
microspheres by adsorption or covalent crosslinking. Figure 2
schematically summarizes experimental treatments and the
time course over which each was applied. Control microspheres
(no agrin or with BSA) were prepared as described above. As
a negative control to solution-phase agrin in culture medium,
culture medium of the appropriate type was used without added
agrin.
C2C12 Cell Response to Solution-Phase
Agrin and Agrin-Adsorbed Microspheres
on 2D Fibrin Gels In vitro
In order to assess whether agrin adsorbed to microspheres could
achieve similar AChR clustering to solution-phase agrin, we
delivered agrin alone or adsorbed to microspheres from solution
or in suspension, respectively. These solutions were provided to
C2C12 cells seeded on a thin sheet of fibrin on a glass coverslip,
FIGURE 2 | Schematic of treatments and fluorescence microscopy techniques used. For each experiment, culture media and agrin treatment time courses
are shown from the day of cell seeding (d0) to the end of the experiment (d8 for 2D experiments or d5 for the 3D experiment). The period of bioreactor
preconditioning is also shown for the 3D experiment. Further, each experiment is designated by the type of fluorescence microscopy used to image relevant
samples – either epifluorescence (Epi.) and / or confocal (Con.).
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which we refer to as a 2-D gel. Both sides of 12 mm diameter
round glass coverslips (Leica Microsystems, Buffalo Grove, IL,
USA) were mechanically roughened with sandpaper to provide
an adherent surface for the fibrin hydrogels. We note that without
roughening, we were unable to achieve stable contact between
fibrin hydrogels and the glass coverslips, but we did not observe
any optical interference and all samples were treated in the same
fashion. The coverslips were then rinsed with DI water, then
dried. 7 µL fibrinogen (Sigma) at 10 mg/mL (∼29 µM) in PBS
was mixed with 10 µL of a thrombin working solution containing
16.7 U/mL thrombin and 367 µg/mL (∼3.3 mM) CaCl2 (both
Sigma) in PBS and spreading the mixture evenly across the glass
surface. After gelation, coverslips were placed into individual
wells of a 24-well dish and then sterilized by exposure to ≥1
MRad γ radiation.
C2C12 mouse myoblasts (ATCC, Manassas, VA, USA) were
suspended in C2C12 growth medium to a concentration of 50,000
cells/mL and then 1 mL of this suspension was added to each
well-containing a fibrin-coated coverslip. After 16–24 h for cell
attachment, growth medium was removed and replaced with
differentiation medium supplemented with aprotinin (Sigma) at
20 µg/ml (∼3.1 µM) to inhibit fibrinolysis. This supplemented
differentiation medium was exchanged every 2–3 days. After
6 days of culture in differentiation medium, either (1) aprotinin-
supplemented differentiation medium alone, (2) a solution of
agrin in aprotinin-supplemented differentiation medium, (3) a
suspension of control microspheres (no agrin) at ∼1.2 million
particles/mL in aprotinin-supplemented differentiation medium,
or (4) a suspension of agrin-adsorbed microspheres at ∼1.2
million particles/mL in aprotinin-supplemented differentiation
medium was added to each well. Cells were then left for
an additional 16–24 h to allow any AChR clustering to
occur before being evaluated by histology and epifluorescence
microscopy as described below. Concentrations of microspheres
in suspension within culture medium here and in subsequent
experiments were based on pilot studies that allowed enough
microspheres to contact cells and remain throughout subsequent
processing while not obscuring the cell layer during histological
processing.
C2C12 Cell Response to Covalently
Bound Agrin Microspheres on 2D Fibrin
Gels In vitro
After evaluation of the microspheres delivered from solution, we
then investigated incorporation of the microspheres directly into
2D fibrin hydrogels to determine if AChR clustering could be
obtained. Pilot studies indicated desorption of agrin from the
microspheres during this process, so we elected to use covalently
coupled agrin for these experiments. Aprotinin supplementation,
medium changes, and histology were performed as above, but
experimental particles presenting covalently immobilized agrin
or control microspheres were added to C2C12 cell-seeded fibrin
gels after only 2 days of culture in differentiation medium,
allowing for 5 days of cell-microsphere contact. Staining,
evaluation of AChR localization using confocal microscopy, and
image processing were performed as described below.
Fibrin gels were polymerized on glass coverslips by methods
similar to those above with a minor change that all materials
were filter sterilized rather than subjected to gamma irradiation
in order to avoid possible degradation of agrin. 10 µL of
10 mg/mL fibrinogen solution containing a suspension of ∼124
million/mL covalently bound agrin Fluoresbrite R© particles or of
untreated control Fluoresbrite R© microspheres was polymerized
by adding 2 µL of a solution consisting of 125 U/mL thrombin
and 2.75 µg/mL (∼25 mM) CaCl2 in PBS. This concentration
of microspheres was used to approximate a fibrin surface with
a roughly equal number of microspheres to those provided
in suspension in previous experiments. C2C12 cells were
then seeded, cultured, stained, and imaged as above. Because
microspheres were immobilized within the gel prior to cell
seeding, no microspheres of any kind were added from the
solution phase.
3D In vitro Model System for Evaluation
of the Response of Rat MDCs to
Agrin-Containing Fibrin Materials
Combined with Mechanical Strain
We fabricated custom 3D fibrin hydrogels containing agrin
microspheres in order to assess the behavior of cells within
a construct suitable for cyclic strain bioreactor conditioning
previously used by our group (see Figure 1 for schematic
overview). These 3D fibrin scaffolds were fabricated by methods
similar to those previously described (Scott et al., 2011). CA fibers
(generous donation of Eastman Chemical Company, Kingsport,
TN, USA) ∼12 µm in diameter were arranged into an aligned
mat roughly 35 mm long× 1 mm thick. Experimental covalently
bound SiO2 agrin microspheres or control covalently bound BSA
microspheres were suspended in 200 mg/mL fibrinogen at a
density of ∼24 million particles/mL, and this suspension was
added to the fibers until the mat was completely impregnated.
Fibrinogen was polymerized to fibrin by adding a solution of
125 U/mL thrombin and 2.75 µg/mL (∼25 mM) CaCl2 in PBS
and leaving undisturbed for at least 4 h at ∼22◦C. The scaffold
was then trimmed into individual smaller scaffolds measuring
roughly 30 mm long × 3 mm wide × 1 mm thick using a razor
blade. These were then sequentially washed, first in acetone and
then in sterile PBS, to yield sterilized 3D scaffolds of known
mechanical properties and morphology (Scott et al., 2011).
Separately, rat MDCs were obtained from 4 to 6 week old
male Lewis rats (Charles River, Raleigh, NC, USA) and were
isolated as previously described (Machingal et al., 2011; Corona
et al., 2012). This isolation protocol was approved by the Wake
Forest University Institutional Animal Care and Use Committee.
Expanded rat MDCs were used for seeding at the second passage.
Representative images of these cells are available as published
previously (Machingal et al., 2011; Corona et al., 2012, 2014).
One 30 mm long× 3 mm wide piece of fibrin scaffold was then
seeded with rat MDCs by manually pipetting∼30 µL suspension
per scaffold of 3 × 107 cells/mL in rat MDC growth medium
over a closely packed side-by-side arrangement of scaffolds.
After 30 min for cell attachment, 700 µL of rat MDC growth
medium per scaffold was added to immerse the cell-seeded
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scaffolds. The experimental groups were fibrin scaffolds with
agrin microspheres or BSA microspheres (control). One group
of each experimental cell-seeded scaffold were left mechanically
undisturbed for 6 days (static culture), while a second group
was removed from static culture after 16–24 h (to allow cell
attachment) and then immediately clamped into the mounts of
a custom-fabricated bioreactor. This bioreactor was similar to
those previously described (Moon du et al., 2008; Machingal et al.,
2011; Corona et al., 2012), consisting of a medium reservoir, a
computer-controlled electromagnetic linear actuator, and a series
of opposing clamps to suspend scaffolds within the medium
reservoir while anchoring one scaffold end to a fixed point and
the other to the linear actuator. The bioreactor was used to
“precondition” cell-seeded scaffolds by subjecting them to 10%
mechanical strain parallel to the long axis of scaffolds three times
per minute for the first 5 min of every hour over a total time of
5 days, consistent with our previous reports (Moon du et al., 2008;
Machingal et al., 2011; Corona et al., 2012).
In all groups, rat MDC growth medium was exchanged every
2–3 days and was supplemented with aprotinin starting on day 3.
After 6 days, AChR localization in muscle cells associated with
the scaffold was evaluated by histology and imaging methods
described below.
Histofluorescence
C2C12 cells on 2D fibrin gels were evaluated histologically while
still attached to coverslips. Gel-adherent cells were fixed in 10%
neutral-buffered formalin (Leica) for 3–5 min, washed three
times for 5 min each in TBST (Dako, Glostrup, Denmark),
blocked against non-specific binding by using a blocking buffer
consisting of 5% v/v horse serum in TBST for at least 30 min
at ∼22◦C, stained for AChR localization by α-bungarotoxin
conjugated with Alexa Fluor 594 (α-BTX, Invitrogen) at 100
nM dilution in blocking buffer for at least 1 h at ∼22◦C in the
dark, washed a further three times in TBST, mounted to glass
slides with Vectashield containing DAPI (Vector Laboratories,
Burlingame, CA, USA) and dried overnight at 4◦C.
3D cell-seeded scaffolds were removed whole from
bioreactors, fixed by immersion in 4% paraformaldehyde in
PBS for 16–24 h at 4◦C, and paraffin processed in an ASP300
tissue processor (Leica). Processed samples were then mounted
into paraffin blocks and longitudinally sectioned on a microtome
to 15 µm thickness, with the plane of the section perpendicular
to the 30 mm × 3 mm plane of the scaffold. Tissue sections were
immobilized on glass slides, dried for 16–48 h at 60◦C, and then
left indefinitely at ∼22◦C until stained. Prior to staining, slides
were deparaffinized by sequential washes in xylenes, ethanol,
and tap water. Staining was then performed as for 2D samples,
beginning with the initial three washes of TBST. We note that
no antigen retrieval was required for successful bungarotoxin
staining, presumably due to the relatively small size of this
molecule compared to monoclonal antibodies typically used for
immunohistochemistry.
Sample Imaging and Image Processing
Epifluorescence and confocal microscopy were used to evaluate
AChR staining in 2D samples. Epifluorescence images were
obtained by using a DM4000 B microscope (Leica) with attached
Retiga 2000RV camera (QImaging, Surrey, BC, Canada), coupled
with ImagePro 6.2 software (Media Cybernetics, Inc., Bethesda,
MD, USA). These epifluorescence images were subsequently
quantified for fluorescence events by a blinded observer.
Fluorescence events were classified as occurring directly adjacent
to a bead, directly underneath (“at”) a bead, or not associated with
a bead. Total bead events were the sum of the “adjacent” and
“at” bead fluorescence. Total fluorescence events were the sum
of the “adjacent” bead fluorescence, “at bead” fluorescence, and
non-bead fluorescence events.
Confocal micrographs of cells on 2D samples (see C2C12
Cell Response to Solution-Phase Agrin and Agrin-Adsorbed
Microspheres on 2D Fibrin Gels In vitro and C2C12 Cell
Response to Covalently Bound Agrin Microspheres on 2D
Fibrin Gels In vitro) or 3D samples (see 3D In vitro Model
System for Evaluation of the Response of Rat MDCs to Agrin-
Containing Fibrin Materials Combined with Mechanical Strain)
were captured on an FV10i confocal microscope (Olympus
America, Center Valley, PA, USA). In both cases, DAPI staining
(405 nm laser at 9.8%) was used to identify cell location by nuclear
staining. Autofluorescence was used to identify microspheres
(2D samples; see Figure 4) or fibrin scaffolds (3D samples;
see Figures 5 and 6), and these were collected with a 473 nm
laser at 16.2%. Alpha-bungarotoxin staining was collected with a
635 nm laser at 68.4%. For each channel (DAPI, autofluorescence,
and alpha-bungarotoxin staining), a variable barrier function
supplied by the microscope manufacturer (Olympus) was used
to automatically select the bandpath wavelength range for
a particular fluorescence dye. The dye sets selected for the
automatic wavelength detector were DAPI (for the 405 nm laser
and DAPI staining), Alexa Fluor 488 (for the 473 nm laser and
fibrin autofluorescence staining) and Alexa Fluor 647 (for the
635 nm laser for alpha-bungarotoxin staining), and sensitivities
were 60.4, 50.0, and 48.4% for each, respectively.
For these confocal images, regions containing cells were
first identified by DAPI staining. These regions containing
cells were then imaged randomly. That is, the regions of
the scaffold materials were randomly selected for areas with
cells. Once these random cellular areas were selected, three-
dimensional projections of sequential confocal z-stacks were
obtained using FIJI image processing software as described
previously (Schindelin et al., 2012). Briefly, the top and bottom
of the nuclei (DAPI) staining were used to estimate the top and
bottom of the cells. A Z-stack image was then collected from
the bottom to the top of the nuclei for each channel noted
above (DAPI, beads or fibrin, and alpha-bungarotoxin). Regions
containing beads were then cropped from the randomly selected
cellular regions. As such, each final rendering comprises one
viewing angle of a 3-D confocal z-stack projected into a 2-D
image.
For the 2D samples, 2D projections of the images (see
Figures 4A,C,E,G) were obtained by importing 3D projections of
individual color channels obtained in the FIJI software to ImageJ
3D Viewer (Schmid et al., 2010) and manually adjusting each
color threshold until DAPI, beads, and bungarotoxin levels were
visually similar to the native 3D projection. Subsequently, the
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images were further processed by thresholding each to the same
level for alpha-bungarotoxin and removing the DAPI (cell nuclei)
signal (Figures 4B,D,F,H).
Acetylcholine receptor localization in 3D samples was imaged
only with confocal microscopy (no epifluorescence). Methods for
confocal microscopy were identical to those described above for
2D samples, except that autofluorescence was use to visualize
fibrin rather than microspheres (possible due to the use of a
different type of microsphere for these 3D experiments). As in
the 2D samples, areas for imaging were selected by viewing
DAPI signals (to select regions containing cells) before images
of the α-BTX stain and fibrin autofluorescence were captured.
Prior to creating a 3D projection of the collected Z-stacks, a
representative region of uniform intensity in the area of fibrin
autofluorescence was located from one confocal Z-slice from each
sample. Intensity within each region was then quantified in each
color spectrum (405 nm wavelength for DAPI, 473 nm for the
fibrin scaffold, and 635 nm for α-BTX) and the mean value from
the selection region’s histogram was recorded. These intensities
were then averaged within each treatment group for each color
(blue, green, or red channel), the treatment group with all color
averages nearest the center of the possible intensity range was
identified, and differences in selection intensity between each
sample and the recorded mean were calculated for each color
channel. To allow comparison of all samples, brightness was
normalized across samples by adjusting maximum intensity in
the FIJI software B&C (Brightness & Contrast) window for each
color channel of each Z-stack image by the calculated difference
from the mean. 3D projection was then performed in the FIJI
software by using normalized Z-stacks, as described above for
2D samples. To quantify the levels of AChR clustering within
the 3D samples, regions of bungarotoxin staining (as indicated
by red color) were selected in Photoshop by a blinded observer.
The intensity per unit area for all selected images was determined
and averaged for each treatment group.
Statistical Analysis
Where appropriate, we used a one-way analysis of variance
(ANOVA) with Tukey’s post hoc analysis in Minitab. Probability
(P) values less than 0.05 were taken to be statistically significant.
RESULTS
Effect of Agrin-Adsorbed Microspheres
on Cultured C2C12 Cells in 2D Fibrin Gel
In vitro
C2C12 cells readily attached to fibrin gels and exhibited an
elongated morphology during 7 days of culture in differentiation
medium. As observed by fluorescent labeling with α-BTX,
these elongated cells often expressed AChRs diffusely within
their membranes (Figure 3A). However, in the absence of
exogenous agrin supplementation, there was no clustering or
other observable spatial organization of these receptors. In
samples treated with agrin dissolved within the culture medium,
detectable AChR clusters were observed on numerous cells within
16 h after treatment, though again without spatial organization or
predictability (Figure 3B). Addition of polystyrene microspheres
in the absence of agrin had no detectable effect on cellular AChR
quantity or location (Figure 3C). In contrast, addition of agrin-
adsorbed microspheres to the cultures resulted in strong AChR
labeling at areas of cell-microsphere contact after as little as
16 h (Figure 3D). Furthermore, there was little or no detectable
AChR clustering on cells distant from an agrin microsphere.
The images shown are representative images of those taken from
FIGURE 3 | Efficacy of agrin treatment in 2D. Representative epifluorescent micrographs of differentiated C2C12 cells stained with fluorescent α-bungarotoxin
summarize the response of cultured muscle cells to agrin presented for 16–24 h prior to staining. (A) Unconditioned cells are diffusely fluorescent when stained,
indicating the presence of AChRs within the membrane. (B) When treated with agrin-conditioned culture medium, AChRs cluster together in a spatially
uncoordinated fashion. (C) Though untreated polystyrene microspheres are visible after addition in suspension due to autofluorescence, there is no AChR clustering
response. (D) AChR clusters are visible in the membranes of cells contacting microspheres carrying surface-adsorbed agrin in a spatially coordinated fashion.
Arrows highlight examples of AChR clustering. Scale bar represents 15 µm in (A–D). (E) Quantification of bungarotoxin fluorescence events for each of the
conditions shown in (A–D). Events were classified as “adjacent to the bead,” “at the bead,” or events not associated with the bead. Total bead-associated events
are combination of “adjacent” and “at bead” events. Total events are combination of “adjacent,” “at bead,” and events not associated with the bead. ∗ Indicates
significantly greater than all other groups (P < 0.05 by Tukey’s post hoc test). # indicates significantly greater than all other groups except agrin in solution (P < 0.05
by Tukey’s post hoc test). N = 4 from a single experiment conducted multiple times. Error bars indicate standard error of the mean.
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FIGURE 4 | Acetylcholine receptor clustering adjacent to agrin-presenting microspheres in 2D. (A,B) After 16–24 h of presenting microspheres by
suspension within culture medium, AChR clusters (red) are present in differentiated C2C12 cells cultured on fibrin and adjacent to microspheres (green) presenting
surface-adsorbed agrin, even in complex cell topographies. (C,D) Similar behavior is observed after 5 days of suspension treatment in cultured cells adjacent to
microsphere surfaces with covalently bound agrin. (E,F) This behavior is maintained when covalently bound agrin microspheres are embedded within the underlying
fibrin gel for the entire 8-day period of culture. (G,H) Region in which cells were present but no bungarotoxin staining was observed. Negative controls (i.e.,
microspheres with no agrin) appeared similar to those shown in (G,H). (A,C,E,G) Represent selected rotational views of a 3D rendered confocal image stack, while
(B,D,F,H) represent the same 3D renders after application of a thresholding algorithm to visually reconstruct microscopic surfaces. Images are from a randomly
selected area of cells. Four separate samples were used to verify repeatability (N = 4). Scale bar represents 10 µm.
FIGURE 5 | Dramatic impact of bioreactor preconditioning on AChR expression and organization in 3D tissue engineered constructs seeded with rat
MDCs. (A–C) Bioreactor preconditioning in constructs with embedded agrin-presenting microspheres induces robust appearance large tracts of AChR clusters
(red), indicating that mechanical stretch and agrin presentation may act synergistically. Very little AChR clustering and no large tracts of AChR clusters were observed
for (D) unstretched (no bioreactor preconditioning) constructs with embedded agrin-presenting or (E) bioreactor preconditioned constructs with embedded
BSA-presenting microspheres. Green color indicates fibrin construct (by autofluorescence) and the DAPI staining (blue) indicates an immature cell phenotype.
(F) Shows the quantification of the bungarotoxin intensity as pixel intensity per unit area as determined by a blinded observer for three separate images (n = 3) from
a bioreactor experiment. Error bars in (F) indicate standard error of the mean and ∗ indicates P < 0.05 of stretched (bioreactor preconditioned) constructs compared
to unstretched (static) agrin-presenting microspheres or stretched (bioreactor preconditioned) BSA-presenting beads. Scale bar represents 20 µm.
four different samples (N = 4) of a single experiment that was
conducted multiple times. Figure 3E shows quantification of
the number and types of fluorescence events as quantified by a
blinded observer for the images shown in Figures 3A–D. Clearly,
most of the events observed occurred at/underneath the bead,
not adjacent to it by this method of quantification. Agrin in
solution had a relatively large number of total events, which were
non-bead events since no beads were present. However, agrin
associated with the microbeads led to significantly more total
events and also showed a reduction in the number of non-bead
fluorescent events.
C2C12 Cell Response to Covalently
Bound Agrin Microspheres on 2D Fibrin
Gels In vitro
To further evaluate the characteristics of the C2C12 cell
response to microsphere-mediated agrin delivery on a 2D fibrin
surface, samples with agrin-adsorbed or covalently bound agrin
were imaged with confocal microscopy and reconstructed in
ImageJ. The use of confocal imaging with laser-power light
sources allowed us to achieve greater contrast and thus better
visualize the behavior at the microsphere-cell interface. Although,
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FIGURE 6 | Representative examples of AChR clustering in a bioreactor-preconditioned agrin-presenting tissue engineered construct. Shown are rat
MDCs (blue nuclei) seeded on the surface of fibrin scaffolds (green autofluorescence) carrying embedded SiO2 microspheres with covalently surface-bound agrin.
Cells exhibited AChR clustering (red) after constructs were subjected to 5 days of cyclic mechanical strain. In contrast to the discrete geometry of AChR clusters
observed under static culture with C2C12 cells (see Figures 3 and 4), AChRs in these rat MDCs cultured on bioreactor-conditioned agrin-presenting scaffolds
clustered into extensive structures of complex geometry (A–D) more reminiscent of the appearance of native MEPs in vivo. By contrast, AChR clusters were never
observed under static 3D culture conditions (compare to Figure 5D), indicating mechanical stretch and agrin presentation may act synergistically in the formation of
mature MEP-like structures in vitro. (A–D) Represent selected magnified views from a 3D-projected confocal z-stack, and are shown in the context of the larger
section (E,F, compare to Figures 5A,C). Scale bars represent 20 µm.
confocal images showed that C2C12 cells sometimes exhibited
AChR clusters (red) a small distance away from agrin-adsorbed
microspheres (Figures 4A,B) after 16–24 h of treatment, agrin
clustering was located near the beads, in agreement with the
results shown in Figure 3.
To evaluate the impact of agrin on AChR clustering over
longer time periods (from 5 to 8 days), covalently bound agrin
microspheres were used. In contrast to observations with agrin-
adsorbed microspheres (Figures 4A,B), AChR clusters near
covalently coupled agrin microspheres were both larger in total
size and more diffusely spread from the area of cell-microsphere
contact (Figures 4C,D). When microspheres with covalently
bound agrin were directly embedded into the underlying fibrin
gel to better mimic the spatial restriction of agrin to the
neuromuscular synapse that would be found in vivo, imaging
revealed that C2C12 cells attached to the fibrin gel, elongated, and
exhibited AChR clusters (Figures 4E,F).
We note that not all beads showed bungarotoxin staining
(indicated by red), and an area of such behavior is shown in
Figures 4G,H. Images shown are from a single experiment
conducted multiple times in quadruplicate (N = 4). The images
shown in Figure 4 (2D experiments) are projections of the
Z-stack, meaning that fluorescent events anywhere in the Z-stack
can be observed.
3D In vitro Model System for Evaluation
of Agrin-Containing Fibrin Materials
Combined with Mechanical Strain
To gain insight into the utility of this approach for in vivo rat
models that use bioreactor pre-conditioning, we also evaluated
the impact of agrin-coated microspheres on rat primary cell
cultures. For these studies, rat MDCs were exposed to agrin
microspheres and/or uniaxial mechanical stretch in a 3D fibrin
gel (see Figure 1). In contrast to 2D fibrin gels seeded with
C2C12 cells, representative images of rat MDC-seeded 3D fibrin
biomaterials revealed little evidence of AChR labeling and no
AChR clustering on statically cultured constructs. This was
true whether the cultured rMDCs were in the absence or
presence of covalently bound agrin microspheres (Figures 5D,E,
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respectively). Rat MDCs seeded on BSA-presenting control
microspheres (i.e., no agrin) embedded in 3D fibrin scaffolds
displayed diffuse AChR labeling after bioreactor preconditioning
(Figure 5C), reminiscent of observations with C2C12 cells in the
static 2D model (see Figure 3A) and at levels similar to those in
statically cultured cells (Figures 5D,E). These AChRs with BSA-
microspheres with bioreactor pre-conditioning were spatially
unorganized, indicating that mechanical strain alone does not
induce AChR clustering. Results are from a single bioreactor
experiment in triplicate (N = 3).
However, rMDCs seeded on agrin-presenting microspheres
embedded in 3D fibrin scaffolds revealed extensive clusters of
AChRs after bioreactor conditioning. Figures 5A–C represent
three different fields of view from this treatment condition.
Interestingly, these clusters were not spatially limited to discrete
areas of cell-particle contact nor were they elliptical in shape as
was often observed in 2D culture (compare to Figure 3D and
Figures 4A–F). Instead, they featured a large, interconnected,
complex geometry (Figures 6A–D). Representative images in
Figures 6A–D are higher magnification images of those in
Figures 6E,F, which are in turn higher-magnification areas
from Figures 5A,C. The images shown in Figures 5 and 6
are projections of the Z-stack, meaning that fluorescent events
anywhere in the Z-stack can be observed.
DISCUSSION
We have previously described (Machingal et al., 2011; Corona
et al., 2012, 2014) a technology that combined biomaterials
(decellularized bladder acellular matrix), rat MDCs, and cyclic
mechanical stretch in a bioreactor to create a TEMR technology
for improved functional restoration of VML injury. Those
studies documented that TEMR implantation into surgically
created VML injuries in mouse LD (Merritt et al., 2010a;
Hinds et al., 2011) and rat TA muscles succeeded in restoring
60–70% of native skeletal muscle force generation within
2 months of implantation, which was significantly greater than
no repair (Machingal et al., 2011; Corona et al., 2012) scaffold
alone (Machingal et al., 2011) or cells on matrix without
preconditioning (Corona et al., 2012). These studies clearly
demonstrated the importance of bioreactor preconditioning to
the development of muscle repair constructs, but the lack of
complete restoration of functional restoration indicates that
additional improvements are required.
In native tissue during development, AChR are diffuse within
the myotube. A motor axon nerve terminal secretes agrin to
induce post-synaptic differentiation. Several additional steps
lead formation of the NMJ, which can persist for the lifetime
of the tissue.(Sanes and Lichtman, 2001). However, in adult
muscle, the loss of the NMJ and related AChR clustering
leads to muscle atrophy or muscle loss (Wang et al., 2013).
Our overarching hypothesis is that one reason for the lack
of complete restoration of function with tissue-engineered
approaches to VML is related to the lack of innervation from
the native peripheral nervous system, which is in turn related
to loss of the key functional phenotype of AChR clustering.
That is, we are suggesting that a key limitation to optimizing
tissue engineering strategies for functional restoration of VML
injuries is the lack of AChR clustering on the implanted
constructs, leading to adverse phenotypic changes that diminish
the potential degree of functional recovery possible, even
when re-innervation of the engineered constructs is eventually
achieved.
The precise role of AChR clustering is not entirely clear.
For example, it is possible that areas of AChR clusters are
not the location of NMJ formation (Kummer et al., 2006)
though these AChR clusters may play a role in that formation
given that the formation of these clusters precedes motor
neuron innervation (Sanes and Lichtman, 1999, 2001). However,
regardless of the precise mechanism, it is well-established that
AChR clustering is an important determinant of the phenotype
of muscle cells. Thus, by extension, the ability to generate
and maintain clustered AChRs in tissue-engineered constructs
would be expected to predispose the muscle cell phenotype
to be more reminiscent of that expected of native muscle. In
this scenario, one might anticipate the functional outcomes
of VML repair to be comparable to that observed in smaller
types of muscle injury in which NMJ do form more rapidly
(Frank et al., 1975; Carlson and Faulkner, 1988; Dedkov et al.,
2002).
In this report, we have described a biomaterial-based strategy
for the spatially controlled delivery of neural agrin and have
characterized the cellular response to these materials for both
a cell line as well as with rat primary cells that would be
suitable for isogeneic grafting procedures for rat in vivo models.
We elected to use fibrin hydrogels as the biomaterial for these
studies for several reasons. First, fibrin is a native component
of the wound healing process and its degradation products are
non-toxic. Fibrin has also been extensively studied as a tissue
engineering substrate for skeletal muscle (Bach et al., 2006;
Dhawan et al., 2007; Bian and Bursac, 2009; Khodabukus and
Baar, 2009; Koning et al., 2009; Hinds et al., 2011; Page et al.,
2011; Martin et al., 2013). In the long-term view, fibrin would
be suitable for clinical applications as it can be autologously
sourced (Linnes et al., 2007) from a patient’s blood, minimizing
the likelihood of an immunological response. Further, fibrin
degrades naturally in vivo on the order of weeks (Linnes et al.,
2007), and can be fabricated to possess mechanical stiffness
similar to native skeletal muscle [Young’s modulus: 110–320 kPa
for a 3D fibrin construct used in this report (Scott et al.,
2011) vs. 7–127 kPa for native muscle tissue (Levinson et al.,
1995)]. A key rationale for the use of fibrin in these proof-
of-concept studies, however, was that it can be fabricated by
methods compatible with the immobilization of agrin-presenting
microspheres within the context of a material of sufficient
strength for bioreactor pre-conditioning (Scott et al., 2011).
The ability to achieve immobilization of the agrin-microspheres
during the fabrication of the materials is important but is not
readily achieved by the bladder acellular matrix constructs used
in our previous studies. Nonetheless, the approach reported here
would likely be compatible with any biomaterial system in which
the agrin-microspheres could be embedded as described here for
fibrin.
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The immobilization of agrin-presenting microspheres as
reported herein is important as the spatial arrangement mimics
the immobilization of agrin within the axonal basal lamina at
a discrete point of contact with the adjacent muscle cell at the
developing synapse (Wu et al., 2010). Although, AChR clustering
has been described in response to adsorbed agrin microspheres
in the literature (Daggett et al., 1996), the current report
provides a much greater level of experimental detail in vitro
of potential relevance to skeletal muscle tissue engineering
in vivo. More specifically, we evaluated not only adsorption
but also covalent linkage of agrin to microspheres, and did
so within the context of an implantable biomaterial system.
This biomaterial-mediated spatial delivery of agrin to muscle
cells in vitro is one step toward testing the hypothesis that an
altered skeletal muscle cell phenotype is ultimately responsible
for lack of full functional recovery following implantation in
tissue engineered muscle constructs for the treatment of VML
injuries- as would be expected, for example, for any skeletal
muscle cell exposed to long term neuronal denervation. Thus,
it is important to note that the goal of these studies was
not to create functional muscle tissue in vitro, but rather, to
illustrate the ability to modulate key aspects of muscle tissue
formation in vitro with the ultimate goal of using these initial
findings to create more enabling technologies for muscle repair
in vivo.
Specifically, after 7 days of culture in 2D fibrin gels,
microspheres were added to C2C12 cells (Figures 3C,D).
Despite microsphere autofluorescence, α-BTX staining was
readily detectable. With agrin presented in solution, spatially
uncoordinated AChR clusters were observed (Figure 3B). By
contrast, agrin microspheres adjacent to cells (Figure 3D, see
arrows) were often observed to have an adjacent fluorescence
bright spot at the cell interface. Since C2C12 cells expressed
some AChRs even in the absence of agrin, we conclude
that the major impact of agrin is not on the presence of
AChR receptor expression per se, but rather on the extent
of AChR clustering. This is borne out in the quantification
of fluorescence events in the C2C12 cells where agrin coated
beads led to significant levels of fluorescence events compared
to beads only (no agrin), cells not exposed to agrin, or
cells exposed to solution phase agrin. It is noteworthy that
the use of agrin adsorbed to beads led to a decrease non-
bead fluorescence events (indicated by # in Figure 3E),
suggesting that the localization of the agrin promotes more
clustering of the AChR in cells cultured on two-dimensional
materials.
3D reconstruction of confocal images revealed that agrin
microspheres directly contacted cells after settling from
suspension. Further, AChR clusters were closely associated
with the cell-microsphere interface (Figures 4A,B). Although,
hydrogels are known depots for protein delivery (Davis, 1974;
Gombotz and Pettit, 1995; Cleland et al., 2001; Mellott et al.,
2001; Hatefi and Amsden, 2002; Leach and Schmidt, 2005),
diffusion-based release of the protein (Leach and Schmidt, 2005)
leads to eventual depletion from the system. By contrast, coupling
agrin to the surface of a microsphere allows spatial control of
both location and dose, preventing diffusion and providing
a biomimetic mechanism (Wu et al., 2010) by which AChR
clustering can be maintained by continual presentation. The lack
of diffusion away from the microsphere carrier suggests that
AChR clustering could potentially be maintained throughout
bioreactor pre-conditioning and even until innervation occurs in
an in vivo implantation scenario.
In contrast to adsorbed agrin microspheres, which were
only added in suspension to C2C12 cells over shorter time
points, covalently bound agrin microspheres were added to
C2C12 cells on 2D fibrin for the last 5 days of culture.
Though, the AChR clusters observed were less spatially
restricted to areas of cell-particle contact than those observed
near agrin-adsorbed microspheres (compare Figures 4C,D to
Figures 4A,B), they were often larger, potentially as a result of
longer-term agrin presentation. These initial data demonstrate
the utility of covalently coupling agrin to microspheres
for longer-term signaling of muscle cells. Covalently linked
agrin microspheres were also embedded within the fibrin
hydrogel to create a more native-like agrin-presenting substrate
for cell attachment. Confocal imaging revealed abundant
AChR clusters on cell surfaces near immobilized microspheres
(Figures 4E,F), demonstrating that immobilized functional agrin
microspheres could be easily incorporated into 3D scaffolds.
As discussed below for the 3D constructs, the effects of
more diffuse AChR labeling remain to be elucidated, but
the ability to form and/or maintain AChR clustering is an
important phenotypic characteristic achieved by the approach
described.
Due to their ready availability and expandability, C2C12
cells were used in the initial in vitro experiments to identify
key parameters (e.g., agrin:microsphere ratio, number of
microspheres). However, for the 3D model system, we evaluated
the effects of agrin on rat MDCs, as this would be most applicable
to their potential use in in vivo rodent models of VML injury
repair and regeneration (Moon du et al., 2008; Machingal et al.,
2011; Corona et al., 2012). We note that that 3D fibrin scaffolds
used a sacrificial templating approach (Scott et al., 2011) able to
promote the aligned phenotype of skeletal muscle. For fabrication
of these 3D fibrin constructs, it is necessary to use solvent washes
(in this case, acetone) to remove the sacrificial fibers. For this
reason, SiO2 particles were used because they do not readily
dissolve in acetone the way that polystyrene beads used in the
2D gels would. We do recognize that neither the polystyrene
nor SiO2 microspheres used in these studies will ultimately be
suitable for use in vivo. Instead, a biodegradable microsphere
system that is not readily soluble in acetone would be necessary to
prevent a large foreign body/inflammatory response to the agrin
microspheres. However, we elected to use these materials in these
proof-of-concept studies to avoid confounding factors related to
carrier degradation (e.g., release of soluble agrin with degradation
of the microsphere).
For these experiments, the effect of mechanical precon-
ditioning on AChR clustering on rat MDCs in surface-seeded
constructs was evaluated in combination with covalently linked
agrin microspheres or with microspheres not containing agrin
(i.e., in scaffolds incorporating microspheres with covalently
linked BSA). Little AChR expression was observed in the
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statically cultured (i.e., no bioreactor preconditioning) group
with agrin microspheres (Figure 5D). Similarly, a small amount
of AChR can be observed in bioreactor preconditioned constructs
incorporating BSA microspheres (Figure 5B); however, this
labeling was faint, was not detected by the blinded observer,
and was similar to that observed in differentiated C2C12
cells not treated with agrin (compare to Figures 3A and
3C). In contrast, AChR clustering was exclusively observed
in preconditioned, agrin-presenting constructs (Figures 5A–C)
and was widespread across the cell-seeded surface. Combined
with the randomized method of selecting areas for imaging
(see Materials and Methods), these results strongly suggest that
AChR clustering results from a synergistic effect of mechanical
stretch and exogenous agrin supplementation. We did not
investigate the precise mechanism(s) behind this behavior and
this remains an area for future investigation. However, given that
intracellular calcium levels play a key role in AChR clustering
in response to agrin (Megeath and Fallon, 1998; Tseng et al.,
2003) this may be a logical starting point for these future
investigations.
An interesting finding from these studies is related to the
morphology of the AChR after the bioreactor pre-conditioning.
The accumulation of AChRs in the MEP of mature synapses takes
on a tortuous morphology (Marques et al., 2000). AChR clusters
observed in preconditioned agrin constructs (Figures 5A–C)
were not confined only to the cell-microsphere interface as
was often observed in 2D (see Figures 3D and 4). Instead,
AChRs clustered into more extensive structures of complex
geometry (Figure 6, which shows Figures 5A–C in higher detail),
reminiscent of the appearance of native MEPs in vivo.
Clearly, the alpha-bungarotoxin staining shown with agrin-
beads in the 3D system (Figures 5 and 6) is quite diffuse in nature
and appears to occur over multiple cells (Figures 5A–C). For
MEP formation, only one set of clusters would be necessary, but
the presence of a diffuse pattern of AChR clustering would not
preclude the formation of MEP formation as the AChR clusters
not involved in MEP formation could be “pruned.” Regardless, it
is apparent that the combination of mechanical stretch and agrin
presentation acted synergistically in vitro, though the effects in an
in vivo model remain to be elucidated.
There are several limitations in this report that warrant further
study. First, the microsphere system delivered only agrin, though
other molecules such as neuregulin likely play a role (Kummer
et al., 2006). Thus, exploration of other molecules alone or
in conjunction with agrin may be able to achieve even more
relevant cell-level effects. Second, we also note that no effort was
made to optimize the levels of agrin on the microsphere surface,
which could impact AChR clustering. In addition, for the studies
reported herein, we simply delivered a sufficient number of agrin-
coated microspheres to elicit a response (i.e., AChR clustering). It
may be necessary to titrate the number of microspheres per cell
and ultimately achieve a ratio of approximately 1 microsphere
per cell in order to have a single set of AChR clusters on the
cell in a manner similar to the developmental process. In this
regard, agrin is known to achieve clustering of existing AChR.
However, it is possible that the use of agrin could lead to long-
term modifications in the mRNA or protein expression profiles
for cells. These could be investigated by quantitative reverse-
transcriptase polymerase chain reaction (qRT-PCR) or Western
blotting, respectively. However, the use of immunohistochemical
imaging used in our studies is preferred for identifying the
spatial localization the existing AChR and was the rationale for
this approach to visualization and quantification of our data.
Finally, we did not document the function of the AChR clusters
so achieved, but rather demonstrated the conditions required
for the in vitro establishment and morphology of the AChRs.
While the conditions to achieve establishment and morphology
of the AChR clusters are clearly important prerequisites in
the technology development pathway for improved repair of
VML injuries, future studies will need to assess the functional
outcomes, likely with in vivo studies.
In short, the results described in this report critically expand
upon existing studies from the literature documenting the
potential utility of agrin supplementation to improved skeletal
muscle tissue engineering approaches for VML injury repair
(Bian and Bursac, 2012; Ko et al., 2013). Primarily, all studies
of this nature to date have evaluated the effects of soluble agrin
stimulation of muscle constructs, either in vitro alone (Bian
and Bursac, 2012) or in vitro prior to implantation in vivo (Ko
et al., 2013). These previous studies demonstrated increased force
production in vitro by engineered constructs (Bian and Bursac,
2012) and, potentially, accelerated innervation of constructs
implanted in vivo (Ko et al., 2013) following agrin stimulation.
The current study documents a method by which the agrin signal
for maintaining AChR clusters may be maintained over longer
periods of time, and moreover, may be more physiologically
relevant, as the agrin presentation in our method is constrained
to the region of contact, and furthermore, amenable to controlled
stoichiometry to achieve and required/desired number of MEP
per myotube/myofiber. Others have used co-culture approaches
that allow nerve axons to achieve AChR clustering (Larkin et al.,
2006; Martin et al., 2015), but such an approach could lead to
competition for the endplate in vivo. Our approach achieves
AChR clustering without competition for innervation between
an existing nerve and a host nerve in an in vivo scenario.
Although our study used fibrin hydrogels and non-degradable
micro-particles, the fundamental methods would be more widely
applicable to other biomaterial systems (hydrogels or other
matrices such as bladder acellular matrix or small intestinal
submucosa) and degradable microparticle systems. That is, this
approach may be used in combination with other strategies
being investigated that use other materials, cells sources, or
pharmacological approaches. As such, these studies represent
a potentially useful extension to previous tissue engineering
approaches to skeletal muscle regeneration and also provide
a bridge to more enabling technologies to existing TEMR
technology platforms for treatment of VML injury.
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